Daily calcium intake among adults appears to vary quite widely around the world in distinct regional patterns, according to a new systematic review of research data ahead of World Osteoporosis Day on Friday, Oct. 20.
Oct 18, 2017
1
0
A new clinical guide summarizes the evidence regarding the effects of calcium in reducing the risk of osteoporosis after the menopause.
Oct 12, 2017
0
1
Osteoporosis is a common disorder among postmenopausal women which results in an increased risk of fractures. While several therapies improve bone strength and reduce the risk of spine and hip fracture, there is no cure for ...
Oct 11, 2017
0
45
(HealthDay)—Romosozumab treatment followed by alendronate is linked to reduced risk of fractures versus alendronate alone for postmenopausal women with osteoporosis, according to a study published online Sept. 11 in the ...
Sep 12, 2017
0
1
(HealthDay)—Bone health is literally something you build on throughout your life, not just as a child. And the efforts you put in now will keep bones strong and help prevent the bone-thinning disease osteoporosis later ...
Aug 9, 2017
0
2
Treatment for osteoporosis may also help prevent gum disease, according to new University at Buffalo research that examined the prevalence of periodontitis in postmenopausal women.
Jul 18, 2017
0
11
Type 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge. A comprehensive review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism ...
Jun 21, 2017
0
0
According to the National Center for Biotechnology Information, approximately 1.5 million Americans suffer osteoporosis-related fractures each year. Although comprehensive care for fragility fractures is available to patients, ...
May 30, 2017
0
0
The American College of Physicians (ACP) recommends in an evidence-based clinical practice guideline published today in Annals of Internal Medicine that physicians treat women with osteoporosis with bisphosphonates (alendronate, ...
May 8, 2017
0
1
(HealthDay)—For postmenopausal breast cancer patients receiving aromatase inhibitors, oral osteoporosis therapy (OPT) is associated with improved survival, according to a study published online May 2 in Cancer.
May 8, 2017
0
0
